Results 171 to 180 of about 12,863,015 (313)

Status, barriers and facilitators of comprehensive abortion care services in rural India: A multicenter mixed-methods study protocol. [PDF]

PLoS One
Manna S, Mishra BK, Yadav KK, Dhiman P, Sahoo S, Mishra C, Rehman T, Prusty RK, Kulkarni R, Bhise M, Pandey AK, B S R, Bhowmick IP, Palo SK, D M NS, Srivastava N, Alam U, Singh R, Barvaliya M, Kandpal V, Gadapani Pathak B, Mukherjee R, Pati S.   +22 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Prevalence and risk factors of adverse work outcomes among manufacturing workers with Long COVID in Malaysia - A nationwide study. [PDF]

PLoS One
Mohd Yusoff H, Yew SQ, Mohd Nawi A, Mohd Tohit N, Abdul Kadir NB, Abd Rahman A, Dapari R, Htwe O, Muhamad Hasani MH, Ramasamy S, Mohamad Z, Abdul Rashid R, Sahani M, Abu Bakar A, Ismail IR, Muhamad Noordin MA, Mohd F, Sakina A, Amnani K.   +18 more
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Bengali manuscript

Manuscript volume bound in red ...

core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Manuscript Collections

The Annals of Iowa, 1986
openaire   +1 more source

Navigated First-Stage L1-S1 Lateral Interbody Fusion in Minimally Invasive Adult Spinal Deformity: Accuracy Rate, Surgical Time, and Technical Considerations. [PDF]

Neurosurg Pract
Kim TY, Khalifeh K, Jubran JH, Gong J, Pham MH.   +4 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Design and implementation of a multi-country targeted health facility assessment to measure integrated, people-centered, quality of services. [PDF]

PLOS Glob Public Health
Gupta S, Kaur J, Jain R, Rowe AK, Jha P, Raji R, Arakal A, White C, Mwencha M, Mabuchi S.   +9 more
europepmc   +1 more source